ferric subsulfate solution
coopersurgical, inc. - ferric subsulfate (unii: 3qj8ws6v8h) (ferric cation - unii:91o4lml611) - astringyn® is a styptic agent used for achieving local hemostasis. in punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds.1 one method for applying ferric subsulfate solution for dermal use consists of the physician placing fingers at the opposite edges of the wound and stretching the skin. the wound is then wiped with gauze, the ferric subsulfate solution applied, and the tension maintained for approximately 15 seconds.2
sodium ferric gluconate complex in sucrose injection
hikma pharmaceuticals usa inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. sodium ferric gluconate complex in sucrose injection is contraindicated in patients with known hypersensitivity to sodium ferric gluconate or any of its components. reactions have included anaphylaxis [see warnings and precautions (5.1) ]. risk summary parenteral iron administration may be associated with hypersensitivity reactions [see warnings and precautions (5.1) ], which may have serious consequences, such as fetal bradycardia (see clinical considerations ). advise pregnant women of the potential risk to the fetus. available data from postmarketing reports with sodium ferric gluconate complex in sucrose injection use in pregnancy are insufficient to assess the risk of major birth defects and miscarriage. sodium ferric gluconate comple
sodium ferric gluconate complex in sucrose injection
hikma pharmaceuticals usa inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. sodium ferric gluconate complex in sucrose injection is contraindicated in patients with known hypersensitivity to sodium ferric gluconate or any of its components. reactions have included anaphylaxis [see warnings and precautions (5.1) ]. risk summary parenteral iron administration may be associated with hypersensitivity reactions [see warnings and precautions (5.1) ], which may have serious consequences, such as fetal bradycardia (see clinical considerations ). advise pregnant women of the potential risk to the fetus. available data from postmarketing reports with sodium ferric gluconate complex in sucrose injection use in pregnancy are insufficient to assess the risk of major birth defects and miscarriage. sodium ferric gluconate comple
injectafer 50 mg/ml inj./inf. disp. i.v. vial
vifor france s.a. - iron carboxymaltose 180 mg/ml - eq. iron 50 mg/ml - dispersion for injection/infusion - 50 mg/ml - ferric carboxymaltose 180 mg/ml - iron, parenteral preparations
injectafer 50 mg/ml inj./inf. disp. i.v. vial
vifor france s.a. - iron carboxymaltose 180 mg/ml - eq. iron 50 mg/ml - dispersion for injection/infusion - 50 mg/ml - ferric carboxymaltose 180 mg/ml - iron, parenteral preparations
injectafer 50 mg/ml inj./inf. disp. i.v. vial
vifor france s.a. - iron carboxymaltose 180 mg/ml - eq. iron 50 mg/ml - dispersion for injection/infusion - 50 mg/ml - ferric carboxymaltose 180 mg/ml - iron, parenteral preparations
ferinject® 50 mg ironml solution for injectioninfusion
zuellig pharma sdn bhd - ferric carboxymaltose -
monoferric solution
pharmacosmos a/s - iron (ferric derisomaltose) - solution - 100mg - iron (ferric derisomaltose) 100mg - iron preparations
g-ferric injection
gonoshasthaya pharmaceuticals ltd. - ferric carboxymaltose - injection - 500 mg/10 ml
ferric subsulfate
qpharma pty ltd - ferric subsulphate - unknown - ferric subsulphate mineral-sulfate active 0.0 - active constituent